Ellevest Inc’s Quest Diagnostics DGX Stock Holding History

Ellevest Inc’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$257K	Buy	+1,217	New	+$239K	0.03%	389
2022 Q3	–	Sell	-41	Closed	-$5K	–	1666
2022 Q2	$5K	Hold	41	–	–	﹤0.01%	1004
2022 Q1	$6K	Buy	+41	New	+$5.71K	﹤0.01%	974
2021 Q3	–	Sell	-9	Closed	-$1K	–	1443
2021 Q2	$1K	Sell	9 -320	-97%	-$41.9K	﹤0.01%	1137
2021 Q1	$42K	Hold	329	–	–	0.01%	514
2020 Q4	$39K	Sell	329 -275	-46%	-$33.5K	0.01%	513
2020 Q3	$69K	Sell	604 -14	-2%	-$1.65K	0.01%	323
2020 Q2	$70K	Buy	618 +88	+17%	+$9.33K	0.02%	303
2020 Q1	$43K	Buy	530 +45	+9%	+$4.66K	0.01%	258
2019 Q4	$52K	Buy	485 +480	+9,600%	+$50.1K	0.01%	183
2019 Q3	$1K	Buy	+5	New	+$513	﹤0.01%	382

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Ellevest Inc's DGX Position: Q2 2026 in Review

Ellevest Inc opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,217 shares worth $257K. The stake represents 0.03% of the portfolio and ranks #389 among its holdings. This is a return to the name: Ellevest Inc previously reported a position in DGX as recently as Q2 2022.

Ellevest Inc first reported a position in DGX in Q3 2019 and has held it in 11 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Ellevest Inc held 1,217 shares of Quest Diagnostics worth $257K as of Q2 2026.
Quest Diagnostics was a new Ellevest Inc position in Q2 2026.
Quest Diagnostics made up 0.03% of Ellevest Inc's portfolio in Q2 2026, its #389 holding.
Ellevest Inc first reported a position in Quest Diagnostics in Q3 2019 and has held it in 11 quarters since.
1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.